Klin Farmakol Farm. 2024;38(2):72-75 | DOI: 10.36290/far.2024.012

Clinical aspect of the provision of pharmacy care in community pharmacies

Zuzana Mačeková1, Peter Matejka2, Ján Klimas3, Ondrej Sukeľ4, Miroslava Snopková2, 4, 5
1 Univerzita veterinárskeho lekárstva a farmácie v Košiciach, Katedra lekárenstva a sociálnej farmácie, Košice
2 Farmaceutická fakulta Univerzity Komenského v Bratislave, Fakultná lekáreň, Bratislava
3 Farmaceutická fakulta Univerzity Komenského v Bratislave, Katedra farmakológie a toxikológie, Bratislava
4 Slovenská lekárnická komora, Bratislava
5 Farmaceutická fakulta Univerzity Komenského v Bratislave, Katedra organizácie a riadenia farmácie, Bratislava

The current concept of the profession of pharmacist is changing and "traditionally" provided pharmaceutical care is gradually expanding to include pharmacy services such as clinical pharmacy, which are directly focused on the individual patient. The professional competencies of pharmacists are expanding globally and are becoming a casual part of pharmaceutical care worldwide. Currently, for increased pressure on primary care, it is necessary that pharmacist fully participate in prevention programs and are involved in the healthcare of patients with chronic diseases. A crucial step for Slovak pharmacy and development of clinical services in community pharmacies is the creation of standard procedures approved by the Ministry of Health of the Slovak Republic, which should become the common base for the performance of prevention programs and management of patients with suspected acute diseases in the conditions of community pharmacies.

Keywords: pharmacist, standard recommendations, physical and biochemical measurements, support of health, prevention, management of disease.

Accepted: June 28, 2024; Published: July 15, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mačeková Z, Matejka P, Klimas J, Sukeľ O, Snopková M. Clinical aspect of the provision of pharmacy care in community pharmacies. Klin Farmakol Farm. 2024;38(2):72-75. doi: 10.36290/far.2024.012.
Download citation

References

  1. Farris KB, Fernandez-Llimos F, Benrimoj SCh. Pharmaceutical Care in Community Pharmacies: Practice and Research from Around the World. Annals of Pharmacotherapy. 2005;39(9):1539-1541. Go to original source... Go to PubMed...
  2. PGEU Annual Report. Chronic medicine shortages affect patients' health and pharmacy practice. [Internet]. 2023. p. 2-5 [cited 2024 January 17]. Available from: https://www.pgeu.eu/wp-content/uploads/2024/03/Annual-Report-2023-Version 3.2 (pgeu.eu)-Version-FINAL.pdf.
  3. The World Health Organisation Cardiovascular diseases Risk Chart Working Group World. Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lacet Glob. Health. 2019;7:1332-1345.
  4. World Health Organisation. Global strategy and action plan on ageing and health. [Internet]. Geneva: World Health Organization; 2017 [cited January 19]. Available from: http://www.iris.who.int/bitstream/handl/10665/329960/9789241513500.
  5. Garattini S, Natsis Y, Banzi R. Pharmaceutical Strategy for Europe: Reflections on Public Health-Driven Drug Development, Regulation, and Policies. Front Pharmacol. 2021;12:685604. Go to original source... Go to PubMed...
  6. Chang ES, Kannoth S, Levy S, et al. Global reach of ageism on older persons' health: A systematic review. PLoS One. 2020;15(1):e0220857. Go to original source... Go to PubMed...
  7. Zákon č. 362/2011 Z. z. o liekoch a zdravotníckych pomôckach.
  8. Svarstad BL, Kotchen JM, Shireman TI, et al. Improving refill adherence and hypertension control in black patients: Wisconsin TEAM trial. J Am Pharm Assoc. 2013;53:520-529. Go to original source... Go to PubMed...
  9. Jahangard-Rafsanjani Z, Hakimzadeh N, Sarayani A, et al. A community pharmacy-based cardiovascular risk screening service implemented in Iran. Pharm Pract (Granada). 2017;15(2):919. Go to original source... Go to PubMed...
  10. Via-Sosa MA, Toro C, Travé P, March MA. Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study. BMC Public Health. 2014;22(14):487. Go to original source... Go to PubMed...
  11. Willis A, Rivers P, Gray LJ, et al. The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting. PLoS One. 2014;9(4):e91157. Go to original source... Go to PubMed...
  12. Štandardný postup pre výkon prevencie kardiovaskulárnych ochorení v podmienkach verejných lekární. ŠP 042. Vestník Ministerstva zdravotníctva SR. Osobitné vydanie. 15. 1. 2023. Ročník 71.
  13. Štandardný postup pre výkon prevencie ochorení pečene v podmienkach verejných lekární. ŠP 056. Vestník Ministerstva zdravotníctva SR. Osobitné vydanie. 15. 1. 2024. Ročník 72.
  14. Štandardný postup pre výkon skríningu a prevencie (pre)obezity v podmienkach verejných lekární. ŠP 055. Vestník Ministerstva zdravotníctva SR. Osobitné vydanie. 15. 1. 2024. Ročník 72.
  15. Štandardný postup pre výkon skríningu porúch glukózového metabolizmu a diabetes mellitus 2. typu v podmienkach verejných lekární. ŠP 057. Vestník Ministerstva zdravotníctva SR. Osobitné vydanie. 15. 1. 2024. Ročník 72.
  16. Štandardný postup pre manažment pacientov s podozrením na akútne infekcie horných dýchacích ciest v podmienkach verejných lekární. ŠP 300. Vestník Ministerstva zdravotníctva SR. Osobitné vydanie. 15. 1. 2024. Ročník 72.
  17. Teka NT, Baye AM. Counseling practice of community pharmacists for diabetes mellitus patients in Addis Ababa, Ethiopia. BMC Res Notes. 2018;11(1):700. Go to original source... Go to PubMed...
  18. Al Hamarneh YN, Marra C, Gniadecki R, et al. RxIALTA: evalu­ating the effect of a pharmacist-led intervention on CV risk in patients with chronic inflammatory diseases in a community pharmacy setting: a prospective pre-post intervention study. BMJ Open. 2021;11(3):e043612. Go to original source... Go to PubMed...
  19. Brown TJ, Todd A, O'Malley C, et al. Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analy­sis for smoking cessation. BMJ Open. 2016;6(2):e009828. Go to original source... Go to PubMed...
  20. Sharma S, Kc B, Alrasheedy AA, et al. Impact of community pharmacy-based educational intervention on patients with hypertension in Western Nepal. Australas Med J. 2014;7(7):304-313. Go to original source... Go to PubMed...
  21. Huete L, Manzano-Lista FJ, Aránguez I, Fernández-Alfonso MS. Impact of pharmacist's intervention on reducing cardiovascular risk in obese patients. Int J Clin Pharm. 2019;41(4):1099-1109. Go to original source... Go to PubMed...
  22. Marfo AFA, Owusu-Daaku FT. Exploring the extended role of the community pharmacist in improving blood pressure control among hypertensive patients in a developing setting. J Pharm Policy Pract. 2017;21(1):39. Go to original source... Go to PubMed...
  23. Ha M, Furman A, Al Rihani SB, et al. Pharmacist-driven interventions to de-escalate urinary antimuscarinics in the Programs of All-Inclusive Care for the Elderly. J Am Geriatr Soc. 2022;70(11):3230-3238. Go to original source... Go to PubMed...
  24. Martin P, Tamblyn R, Benedetti A, et al. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial. JAMA. 2018;320(18):1889-1898. Go to original source... Go to PubMed...
  25. Heikkilä JM, Parkkamäki S, Salimäki J, et al. Community pharmacists' knowledge of COPD, and practices and perceptions of medication counseling of COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:2065-2074. Go to original source... Go to PubMed...
  26. Rickles NM, Skelton JB, Davis J, Hopson J. Cognitive memory screening and referral program in community pharmacies in the United States. Int J Clin Pharm. 2014;36(2):360-367. Go to original source... Go to PubMed...
  27. Arikawe O, Morrissey H, Ball P. Community pharmacy brief screening intervention to improve health outcomes for patients diagnosed with chronic diseases. J. Adv. Pharm. Educ. Res. 2022;12(3):1-8. Go to original source...
  28. Brain J, Tully PJ, Turnbull D, et al. Risk factors for dementia in the context of cardiovascular disease: A protocol of an overview of reviews. PLoS One. 2022;17(7):e0271611. Published 2022 Jul 21. doi:10.1371/journal.pone.0271611. Go to original source... Go to PubMed...
  29. Harasani K, Xhafaj D, Lekaj A, et al. Screening for mild cognitive impairment among older Albanian patients by clinical pharmacists. Int J Pharm Pract. 2021;29(2):189-191. Go to original source... Go to PubMed...
  30. Climent MT, Pardo J, Muñoz-Almaraz FJ, et al. Decision Tree for Early Detection of Cognitive Impairment by Community Pharmacists. Front Pharmacol. 2018;9:1232. Go to original source... Go to PubMed...
  31. Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT. Community Pharmacist-Initiated Screening Program for Osteoporosis: Randomized Controlled Trial. Osteoporos Int. 2010;21:391-398. doi:10.1007/S00198-009-0977-Z. Go to original source... Go to PubMed...
  32. Giles JT, Kennedy DT, Dunn EC, et al. Results of a Community Pharmacy-Based Breast Cancer Risk-Assessment and Education Program. Pharmacotherapy. 2001;21:243-253. doi:10.1592/PHCO.21.2.243.34100. Go to original source... Go to PubMed...
  33. Potter MB, Gildengorin G, Wang Y, Wu M, Kroon L. Comparative Effectiveness of Two Pharmacy-Based Colorectal Cancer Screening Interventions during an Annual Influenza Vaccination Campaign. Journal of the American Pharmacists Association. 2010:50. Go to original source... Go to PubMed...
  34. Hughes C, Winterstein A, McElnay J, et al. Improving the Well-Being of Elderly Patients via Community Pharmacy-Based Provision of Pharmaceutical Care: A Multicentre Study in Seven European Countries. Drugs Aging. 2001;18:63-77. Go to original source... Go to PubMed...
  35. West LM, Cordina M. Educational Intervention to Enhance Adherence to Short-Term Use of Antibiotics. Res Social Adm Pharm. 2019;15:193-201. doi:10.1016/J.SAPHARM.2018.04.011. Go to original source... Go to PubMed...
  36. Usami T, Hashiguchi M, Kouhara T, et al. Impact of Community Pharmacists Advocating Immunization on Influenza Vaccination Rates among the Elderly. Yakugaku Zasshi. 2009;129:1063-1068. Go to original source... Go to PubMed...
  37. Matejka P, Švec P, Seginko J, et al. Možnosti stanovenia rizikových faktorov aterosklerózy v podmienkach verejnej lekárne. Slov. Revue. 2003;13(2-3):62-64.
  38. Matejka P, Švec P, Seginko J, et al. Záujem návštevníkov verejných lekární o meranie základných parametrov určujúcich riziko rozvoja aterosklerózy v lekárni. Farm Obzor. 2004;73(8):203-208.
  39. Matejka P, Švec P, Seginko J. Effect of pharmacy-based point of care screening and counselling on patient's global coronary risk Pharmacy World & Science. 2005;27(2):A27-A28.
  40. Matejka P, Švec P. Metodická príručka pre poskytovanie biochemických vyšetrení v lekárni. Bratislava: Univerzita Komenského, Farmaceutická fakulta; 2014: 34 s.
  41. Hwang AY, Gums TH, Gums JG. The benefits of physician-pharmacist collaboration. J Fam Pract. 2017;66(12):E1-E8. PMID: 29202145.
  42. Kelly DV, Bishop L, Young S, et al. Pharmacist and physician views on collaborative practice: Findings from the community pharmaceutical care project. Can Pharm J (Ott). 2013;146(4):218-226. Go to original source... Go to PubMed...
  43. Waszyk-Nowaczyk M, Guzenda W, Kamasa K, et al. Cooperation Between Pharmacists and Physicians - Whether It Was Before and is It Still Ongoing During the Pandemic? J Multidiscip Healthc. 2021;14:2101-2110. Go to original source... Go to PubMed...
  44. Macekova Z, Fazekas T, Stanko P, et al. Cognitive screening within advanced pharmaceutical care in elderly patients with suspected metabolic syndrome. Int. J. Gerontol. 2022;16:355-360.
  45. Macekova Z, Krivosova M, Fazekas T, et al. Short cognitive screening in elderlies as a part of advanced pharmaceutical care in Slovak community pharmacies - The pilot study KOGNIMET-SK. Eur. Pharm. J. 2022;69:37-42. Go to original source...
  46. Macekova Z, Fazekas T, Krivosova M, et al. Identification of a Link between Suspected Metabolic Syndrome and Cognitive Impairment within Pharmaceutical Care in Adults over 75 Years of Age. Healthcare. 2023;11(5):718. Go to original source... Go to PubMed...
  47. Jin H, Huang Y, Xi X, et al. Exploring the training of pharmacists oriented to the demands for clinical pharmacy services: from the perspective of physicians. BMC Med Educ. 2023;23:357. https://doi.org/10.1186/s12909-023-04353-7. Go to original source... Go to PubMed...
  48. Alfian SD, van Boven JFM, Abdulah R, et al. Effectiveness of a targeted and tailored pharmacist-led intervention to improve adherence to antihypertensive drugs among patients with type 2 diabetes in Indonesia: A cluster randomised controlled trial. Br J Clin Pharmacol. 2021;87(4):2032-2042. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.